Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist highly effective for weight loss and blood sugar control. Marketed as Mounjaro for diabetes and Zepbound for obesity, it produces remarkable results surpassing single-receptor agonists. It significantly reduces appetite, promotes substantial weight loss, and improves metabolic health.

What is Tirzepatide?

What are Tirzepatide's main benefits?

What are Tirzepatide's main drawbacks?

How does Tirzepatide work?

Dosage information

Stay up to date

Access the latest research, reviewed and explained in-depth by a multidisciplinary team of experts. Examine is a completely independent organization. No industry ties, no sponsors, no bias.

Join Now

Examine provides institutional access. Contact us for more details.

Join Pro

Eliminate Your Quality Worries

Pro members get access to our database of independently tested Peptides at ISO-accredited laboratories to test for purity, sterility, endotoxins, and heavy metals, the gold standard for quality control.